Ultralife Corporation reported a substantial increase in revenue and operating income for the first quarter of 2020. Revenue increased by 37% and operating profit increased by 171% compared to the same period last year. The company faced challenges due to COVID-19, including a shutdown in China, but managed to maintain operations and invest in growth initiatives.
Revenue increased by 36.7% to $25.8 million, compared to $18.9 million in the first quarter of 2019.
Operating income rose to $1.5 million, a 171% increase from $0.5 million in the prior year.
Net income increased to $1.1 million, or $0.07 per diluted share, compared to $0.4 million, or $0.03 per diluted share, in the first quarter of 2019.
Battery & Energy Products revenues were $20.8 million, compared to $16.0 million last year, primarily reflecting the SWE acquisition.
Ultralife is investing approximately $1 million in the second quarter for additional test equipment to meet the increased demand for power supplies. With a backlog increasing approximately 20% over year-end 2019, ample liquidity, end-market diversity and tight control over discretionary spending, they are well positioned to both sustain operations and continue investing in growth initiatives.
Visualization of income flow from segment revenue to net income